About Bonine
Bonine is a Healthcare company based in Sarasota (United States) founded in 1995, and was acquired by WellSpring Pharmaceutical in September 2014. Drugs and health supplements are manufactured to control morning sickness. Its chief executive, as recorded, is John Dowers. Its website bonine.com draws about 10 thousand monthly visits. Its focus areas include Traditional Pharmaceuticals.
Company details
Bonine was established in 1995 in Sarasota, United States, within the pharmaceutical sector. Focus is placed on the production of drugs and health supplements targeted at managing morning sickness. Operations are centered in the United States, with distribution handled through established channels. Leadership is provided by CEO and President John Dowers. Core activities emphasize regulatory compliance and product formulation for consumer health needs.
- Headquarters Sarasota, United States
- Stage Acquired
- SectorsHealthcare
- Website category Health · Pharmacy
- Website bonine.com
- Social X
- Acquired by WellSpring Pharmaceutical (Sep 2014)
- InvestorsWellSpring Pharmaceutical
& 1 more
- Acquired byWellSpring Pharmaceutical
(Sep 2014)
Investors in Bonine
Bonine has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include WellSpring Pharmaceutical and Sentinel Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and capital solutions are offered by Sentinel. | sentinelpartners.com | New York, United States | ||
Prescription and branded OTC drug maker | 1999 | wellspringpharm.com | Sarasota, United States |
Investor details for Bonine
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bonine
1 people are tracked at Bonine (1 in leadership).
| Name | Role | Group |
|---|---|---|
John Dowers | CEO & President | Leadership |
Complete people profiles for Bonine
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Bonine
2 dated milestones of Bonine across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Bonine is founded.
- Exit Acquired by WellSpring Pharmaceutical.
Web traffic of Bonine
The website of Bonine (bonine.com) receives about 10.1K visits a month and ranks #2,542,709 among all websites worldwide, #3,302 in Pharmacy.
- Monthly visits10.1K
▲ 19.5% vs previous month
- Unique visitors3.6K
per month
- Global rank#2,542,709
among all websites
- Category rank#3,302
Health · Pharmacy
- Bounce rate35%
- Pages per visit1.8
- Average visit38 sec
- DevicesDesktop 29% Β· Mobile 71%
Websites whose visitors overlap most with Bonine. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
dramamine.com | dramamine.com | 100% | #612,609 | β | |
| monistat.com | 89% | 91.1K | #460,996 | View details | |
nixlice.com | nixlice.com | 82% | #857,428 | β | |
| vitronc.com | 82% | #3,584,659 | View details | ||
sucrets.com | sucrets.com | 82% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 13 similar websites and full traffic analytics for Bonine
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Bonine (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bonine
Bonine was founded in 1995.
Bonine is headquartered in Sarasota, United States. It is registered at Sarasota, Florida, United States.
John Dowers is the CEO of Bonine, as recorded in our data.
Bonine was established in 1995 in Sarasota, United States, within the pharmaceutical sector. Focus is placed on the production of drugs and health supplements targeted at managing morning sickness. Operations are centered in the United States, with distribution handled through established channels. Leadership is provided by CEO and President John Dowers. Core activities emphasize regulatory compliance and product formulation for consumer health needs.
Bonine has 2 investors. Key investors include WellSpring Pharmaceutical, and Sentinel Capital Partners.
Yes. Bonine was acquired by WellSpring Pharmaceutical in September 2014.
